Factors Influencing Physical Performance and Quality of Life in Post-COVID-19 Patients
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Participants
2.3. Procedure
2.3.1. Hand Grip Test
2.3.2. Quadriceps Muscle Strength Test
2.3.3. Six-Min Walk Test (6MWT)
2.3.4. Timed Up-and-Go Test (TUG)
2.3.5. Quality of Life (QoL)
2.4. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- National Institute for Health and Care Excellence. COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. In Clinical Guidelines; National Institute for Health and Care Excellence: London, UK, 2020. [Google Scholar]
- Davis, H.E.; Assaf, G.S.; McCorkell, L.; Wei, H.; Low, R.J.; Re’em, Y.; Redfield, S.; Austin, J.P.; Akrami, A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021, 38, 101019. [Google Scholar] [CrossRef] [PubMed]
- Tabacof, L.; Tosto-Mancuso, J.; Wood, J.; Cortes, M.; Kontorovich, A.; McCarthy, D.; Rizk, D.; Rozanski, G.; Breyman, E.; Nasr, L.; et al. Post-acute COVID-19 Syndrome Negatively Impacts Physical Function, Cognitive Function, Health-Related Quality of Life, and Participation. Am. J. Phys. Med. Rehabil. 2022, 101, 48–52. [Google Scholar] [CrossRef]
- O’Mahoney, L.L.; Routen, A.; Gillies, C.; Ekezie, W.; Welford, A.; Zhang, A.; Karamchandani, U.; Simms-Williams, N.; Cassambai, S.; Ardavani, A.; et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine 2023, 55, 101762. [Google Scholar] [CrossRef]
- Gunnarsson, D.V.; Miskowiak, K.W.; Pedersen, J.K.; Hansen, H.; Podlekareva, D.; Johnsen, S.; Dall, C.H. Physical Function and Association with Cognitive Function in Patients in a Post-COVID-19 Clinic-A Cross-Sectional Study. Int. J. Environ. Res. Public Health 2023, 20, 5866. [Google Scholar] [CrossRef] [PubMed]
- Singh, B.M.; Bateman, J.; Viswanath, A.; Klaire, V.; Mahmud, S.; Nevill, A.; Dunmore, S.J. Risk of COVID-19 hospital admission and COVID-19 mortality during the first COVID-19 wave with a special emphasis on ethnic minorities: An observational study of a single, deprived, multiethnic UK health economy. BMJ Open 2021, 11, e046556. [Google Scholar] [CrossRef]
- Yong, S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021, 53, 737–754. [Google Scholar] [CrossRef] [PubMed]
- Walle-Hansen, M.M.; Ranhoff, A.H.; Mellingsæter, M.; Wang-Hansen, M.S.; Myrstad, M. Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19. BMC Geriatr. 2021, 21, 199. [Google Scholar] [CrossRef]
- Huang, L.; Yao, Q.; Gu, X.; Wang, Q.; Ren, L.; Wang, Y.; Hu, P.; Guo, L.; Liu, M.; Xu, J.; et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet 2021, 398, 747–758. [Google Scholar] [CrossRef]
- Garrigues, E.; Janvier, P.; Kherabi, Y.; Le Bot, A.; Hamon, A.; Gouze, H.; Doucet, L.; Berkani, S.; Oliosi, E.; Mallart, E.; et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020, 81, e4–e6. [Google Scholar] [CrossRef]
- Figueiredo, E.A.B.; Silva, W.T.; Tsopanoglou, S.P.; Vitorino, D.F.M.; Oliveira, L.F.L.; Silva, K.L.S.; Luz, H.D.H.; Ávila, M.R.; Oliveira, L.F.F.; Lacerda, A.C.R.; et al. The health-related quality of life in patients with post-COVID-19 after hospitalization: A systematic review. Rev. Soc. Bras. Med. Trop. 2022, 55, e0741. [Google Scholar] [CrossRef]
- Sadat Larijani, M.; Ashrafian, F.; Bagheri Amiri, F.; Banifazl, M.; Bavand, A.; Karami, A.; Asgari Shokooh, F.; Ramezani, A. Characterization of long COVID-19 manifestations and its associated factors: A prospective cohort study from Iran. Microb. Pathog. 2022, 169, 105618. [Google Scholar] [CrossRef] [PubMed]
- Amput, P.; Tapanya, W.; Sangkarit, N.; Konsanit, S.; Wongphon, S. Balance Ability and Quality of Life in Older Adult with Recovery from Mild COVID-19. Ann. Geriatr. Med. Res. 2023, 27, 235–240. [Google Scholar] [CrossRef]
- De Felice, F.G.; Tovar-Moll, F.; Moll, J.; Munoz, D.P.; Ferreira, S.T. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System. Trends. Neurosci. 2020, 43, 355–357. [Google Scholar] [CrossRef]
- Rodríguez-Pérez, M.P.; Sánchez-Herrera-Baeza, P.; Rodríguez-Ledo, P.; Huertas-Hoyas, E.; Fernández-Gómez, G.; Montes-Montes, R.; Pérez-de-Heredia-Torres, M. Influence of Clinical and Sociodemographic Variables on Health-Related Quality of Life in the Adult Population with Long COVID. J. Clin. Med. 2023, 12, 4222. [Google Scholar] [CrossRef] [PubMed]
- Segura-Ortí, E.; Martínez-Olmos, F.J. Test-retest reliability and minimal detectable change scores for sit-to-stand-to-sit tests, the six-minute walk test, the one-leg heel-rise test, and handgrip strength in people undergoing hemodialysis. Phys. Ther. 2011, 91, 1244–1252. [Google Scholar] [CrossRef]
- Mentiplay, B.F.; Perraton, L.G.; Bower, K.J.; Adair, B.; Pua, Y.H.; Williams, G.P.; McGaw, R.; Clark, R.A. Assessment of Lower Limb Muscle Strength and Power Using Hand-Held and Fixed Dynamometry: A Reliability and Validity Study. PLoS ONE 2015, 10, e0140822. [Google Scholar] [CrossRef]
- ATS statement: Guidelines for the six-minute walk test. Am. J. Respir. Crit. Care. Med. 2002, 166, 111–117. [CrossRef] [PubMed]
- Bohannon, R.W. Reference values for the timed up and go test: A descriptive meta-analysis. J. Geriatr. Phys. Ther. 2006, 29, 64–68. [Google Scholar] [CrossRef]
- Nandasena, H.; Pathirathna, M.L.; Atapattu, A.; Prasanga, P.T.S. Quality of life of COVID 19 patients after discharge: Systematic review. PLoS ONE 2022, 17, e0263941. [Google Scholar] [CrossRef]
- Dodds, R.M.; Syddall, H.E.; Cooper, R.; Benzeval, M.; Deary, I.J.; Dennison, E.M.; Der, G.; Gale, C.R.; Inskip, H.M.; Jagger, C.; et al. Grip strength across the life course: Normative data from twelve British studies. PLoS ONE 2014, 9, e113637. [Google Scholar] [CrossRef]
- Bohannon, R.W. Grip Strength: An Indispensable Biomarker for Older Adults. Clin. Interv. Aging. 2019, 14, 1681–1691. [Google Scholar] [CrossRef] [PubMed]
- Montes-Ibarra, M.; Oliveira, C.L.P.; Orsso, C.E.; Landi, F.; Marzetti, E.; Prado, C.M. The Impact of Long COVID-19 on Muscle Health. Clin. Geriatr. Med. 2022, 38, 545–557. [Google Scholar] [CrossRef]
- Yang, G.; Li, Z.; Li, Z.; Huang, L.; Liang, P.; Liu, L.; Li, D. Meta-analysis of the impact of physical activity on the recovery of physical function in COVID-19 patients. Heliyon 2023, 9, e19339. [Google Scholar] [CrossRef] [PubMed]
- Huang, C.; Huang, L.; Wang, Y.; Li, X.; Ren, L.; Gu, X.; Kang, L.; Guo, L.; Liu, M.; Zhou, X.; et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet 2023, 401, e21–e33. [Google Scholar] [CrossRef]
- Studenski, S.; Perera, S.; Patel, K.; Rosano, C.; Faulkner, K.; Inzitari, M.; Brach, J.; Chandler, J.; Cawthon, P.; Connor, E.B.; et al. Gait speed and survival in older adults. Jama 2011, 305, 50–58. [Google Scholar] [CrossRef]
- Torres-Castro, R.; Núñez-Cortés, R.; Larrateguy, S.; Alsina-Restoy, X.; Barberà, J.A.; Gimeno-Santos, E.; García, A.R.; Sibila, O.; Blanco, I. Assessment of Exercise Capacity in Post-COVID-19 Patients: How Is the Appropriate Test Chosen? Life 2023, 13, 621. [Google Scholar] [CrossRef] [PubMed]
- Trombetti, A.; Reid, K.F.; Hars, M.; Herrmann, F.R.; Pasha, E.; Phillips, E.M.; Fielding, R.A. Age-associated declines in muscle mass, strength, power, and physical performance: Impact on fear of falling and quality of life. Osteoporos. Int. 2016, 27, 463–471. [Google Scholar] [CrossRef]
- Rodriguez Lima, D.R.; Rubio Ramos, C.; Diaz Quiroz, M.A.; Rodríguez Aparicio, E.E.; Gómez Cortes, L.A.; Otálora González, L.; Hernández-Herrera, G.; Rondón, Á.M.P.; Sternberg, Á.M.R. Resilience and quality of life in patients who underwent mechanical ventilation due to COVID-19, one year after discharge: A cross-sectional study. J Patient Rep. Outcomes 2024, 8, 70. [Google Scholar] [CrossRef]
- Perez-Rojo, G.; López, J.; Noriega, C.; Velasco, C.; Carretero, I.; López-Frutos, P.; Galarraga, L. A multidimensional approach to the resilience in older adults despite COVID-19. BMC Geriatr. 2022, 22, 793. [Google Scholar] [CrossRef]
- Sadang, J.M.; Palompon, D.R.; Agoncillo, D.J.E.; Datumanong, N.T.; Alawiya, J.T.P. A Multiple Case Study of Older Adults’ Internal Resiliency and Quality of Life during the COVID-19 Health Emergency. Ann. Geriatr. Med. Res. 2023, 27, 158–171. [Google Scholar] [CrossRef]
- MacLeod, S.; Musich, S.; Hawkins, K.; Alsgaard, K.; Wicker, E.R. The impact of resilience among older adults. Geriatr. Nurs. 2016, 37, 266–272. [Google Scholar] [CrossRef] [PubMed]
- Loades, M.E.; Chatburn, E.; Higson-Sweeney, N.; Reynolds, S.; Shafran, R.; Brigden, A.; Linney, C.; McManus, M.N.; Borwick, C.; Crawley, E. Rapid Systematic Review: The Impact of Social Isolation and Loneliness on the Mental Health of Children and Adolescents in the Context of COVID-19. J. Am. Acad. Child. Adolesc. Psychiatry 2020, 59, 1218–1239.e1213. [Google Scholar] [CrossRef] [PubMed]
- Dixon, J.B. The effect of obesity on health outcomes. Mol. Cell. Endocrinol. 2010, 316, 104–108. [Google Scholar] [CrossRef] [PubMed]
- Puhl, R.M.; Heuer, C.A. Obesity stigma: Important considerations for public health. Am. J. Public Health 2010, 100, 1019–1028. [Google Scholar] [CrossRef]
- Melamed, O.C.; Selby, P.; Taylor, V.H. Mental Health and Obesity During the COVID-19 Pandemic. Curr. Obes. Rep. 2022, 11, 23–31. [Google Scholar] [CrossRef]
- Nour, T.Y.; Altintaş, K.H. Effect of the COVID-19 pandemic on obesity and it is risk factors: A systematic review. BMC Public Health 2023, 23, 1018. [Google Scholar] [CrossRef]
Parameters | n (%) | Mean ± SD (Min–Max) | |
---|---|---|---|
Gender | Male Female | 23 (31.10) 51 (68.90) | |
Health status | Underlying disease No underlying diseases | 12 (16.20) 62 (83.80) | |
Age | 43.11 ± 17.23 (20.00–65.00) | ||
Weight (kg) | 57.07 ± 9.72 (6.00–18.00) | ||
Height (m) | 1.63 ± 0.07 (1.50–1.78) | ||
Body mass index | 21.38 ± 2.38 (16.73–25.95) | ||
Waist circumference (cm) | 70.01 ± 4.11 (60.00–78.00) | ||
Hip circumference (cm) | 89.86 ± 5.31 (78.00–99.00) | ||
Systolic blood pressure (mmHg) | 128.26 ± 10.43 (101.0–141.0) | ||
Diastolic blood pressure (mmHg) | 77.11 ± 7.26 (61.0–98.0) | ||
Heart rate (bpm) | 82.12 ± 8.62 (61.0–97.0) | ||
O2 saturation (%) | 98.35 ± 0.65 (97.0–99.0) | ||
Frequency of exercise (day) | 1.51 ± 1.09 (0.00–3.00) |
β ± SE (95% CI) | ||||
---|---|---|---|---|
Factors | Hand Grip (kg) | Quadriceps Strength (kg) | TUG | Distance 6MWT |
Gender | −3.33 ± 0.75 | −5.38 ± 0.63 | −0.33 ± 0.31 | 22.48 ± 11.34 |
(−4.82, −1.83) ** | (−6.65, −4.12) ** | (−0.95, 0.28) | (−0.16, 45.12) | |
p-value | <0.001 ** | <0.001 ** | 0.283 | 0.052 |
Age (year) | −0.05 ± 0.02 | −0.02 ± 0.02 | 0.09 ± 0.01 | −2.24 ± 0.27 |
(−0.09, −0.02) ** | (−0.05, 0.01) | (0.07, 0.10) ** | (−2.78, −1.71) ** | |
p-value | 0.006 * | 0.145 | <0.001 ** | 0.545 |
Duration of COVID-19 (month) | 0.18 ± 0.09 | −0.15 ± 0.07 | 0.02 ± 0.04 | −0.79 ± 1.29 |
(0.01, 0.35) * | (−0.25, −0.01) * | (−0.05, 0.09) | (−3.38, 1.80) | |
p-value | 0.036 * | 0.044 * | 0.552 | 0.545 |
Exercise days (day) | −0.07 ± 0.27 | 0.21 ± 0.23 | 0.15 ± 0.11 | −2.92 ± 4.03 |
(−0.60, 0.46) | (−0.24, 0.65) | (−0.06, 0.37) | (−10.96, 5.13) | |
p-value | 0.794 | 0.362 | 0.168 | 0.472 |
Waist circumference (cm) | −0.12 ± 0.10 | −0.03 ± 0.09 | −0.02 ± 0.04 | −2.31 ± 1.57 |
(−0.33, 0.09) | (−0.21, 0.14) | (−0.11, 0.07) | (−5.05, 0.82) | |
p-value | 0.253 | 0.715 | 0.632 | 0.146 |
Hip circumference (cm) | −0.05 ± 0.08 | −0.05 ± 0.06 | 0.05 ± 0.03 | −0.04 ± 1.15 |
(−0.20, 0.10) | (−0.17, 0.08) | (−0.01, 0.12) | (−2.33, 2.24) | |
p-value | 0.513 | 0.463 | 0.097 | 0.971 |
Body mass index (BMI) | −0.07 ± 0.13 | 0.03 ± 0.11 | −0.04 ± 0.06 | 1.40 ± 2.02 |
(−0.34, 0.19) | (−0.19, 0.26) | (−0.15, 0.07) | (−2.63, 5.42) | |
p-value | 0.591 | 0.765 | 0.484 | 0.490 |
Factors | β ± SE (95% CI) | |||||||
---|---|---|---|---|---|---|---|---|
Physical Function | Physical Role Limitations | Bodily Pain | General Health Perceptions | Vitality | Social Functioning | Emotional Role Limitation | Mental Health | |
Health status | 1.80 ± 1.98 | −1.82 ± 1.73 | −3.02 ± 1.81 | −0.25 ± 1.48 | −1.36 ± 1.70 | 0.40 ± 1.31 | 1.73 ± 0.95 | 0.67 ± 1.08 |
(−2.15, 5.76) | (−5.27, 1.63) | (−6.62, 0.59) | (−3.22, 2.71) | (−4.76, 2.04) | (−2.21, 3.02) | (−1.16, 3.63) | (−1.50, 2.83) | |
p-value | 0.366 | 0.296 | 0.100 | 0.866 | 0.427 | 0.759 | 0.073 | 0.541 |
Age (year) | 0.18 ± 0.51 | 0.18 ± 0.05 | 0.19 ± 0.05 | 0.19 ± 0.04 | 0.15 ± 0.04 | 0.24 ± 0.03 | 0.21 ± 0.02 | 0.14 ± 0.03 |
(0.08, 0.28) * | (0.86, 0.26) * | (0.09, 0.28) ** | (0.11, 0.27) ** | (0.07, 0.24) * | (0.17, 0.31) ** | (0.16, 0.25) ** | (0.08, 0.20) ** | |
p-value | 0.001 * | <0.001 ** | <0.001 ** | <0.001 ** | <0.001 ** | <0.001 ** | <0.001 ** | <0.001 ** |
Duration of COVID-19 (month) | −0.02 ± 0.21 | 0.11 ± 0.18 | −0.03 ± 0.19 | 0.04 ± 0.15 | 0.23 ± 0.18 | 0.32 ± 0.14 | −0.26 ± 0.10 | 0.08 ± 0.11 |
(−0.43, 0.39) | (−0.25, 0.47) | (−0.41, 0.35) | (−0.27, 0.35) | (−0.12, 0.59) | (0.04, 0.59) * | (−0.46, −0.07) * | (−0.15, 0.31) | |
p-value | 0.928 | 0.538 | 0.883 | 0.784 | 0.195 | 0.023 * | 0.010 * | 0.478 |
Exercise days (day) | −0.51 ± 0.67 | −0.41 ± 0.58 | −0.01 ± 0.61 | −0.63 ± 0.50 | 1.15 ± 0.57 | −0.05 ± 0.44 | −0.80 ± 0.32 | 0.65 ± 0.36 |
(−1.84, 0.82) | (−1.57, 0.75) | (−1.22, 1.20) | (−1.63, 0.36) | (0.01, 2.29) | (−0.93, 0.83) | (−1.44, −0.17) * | (−0.08, 1.38) | |
p-value | 0.488 | 0.485 | 0.988 | 0.209 | 0.048 * | 0.915 | 0.014 * | 0.079 |
Waist circumference (cm) | 0.04 ± 0.25 | 0.12 ± 0.22 | 0.17 ± 0.23 | 0.20 ± 0.19 | −0.21 ± 0.22 | 0.01 ± 0.17 | 0.04 ± 0.12 | −0.27 ± 0.13 |
(−0.47, 0.53) | (−0.32, 0.56) | (−0.29, 0.63) | (−0.18, 0.58) | (−0.64, 0.22) | (−0.32, 0.34) | (−0.20, 0.28) | (−0.54, 0.01) | |
p-value | 0.886 | 0.593 | 0.455 | 0.289 | 0.332 | 0.946 | 0.750 | 0.054 |
Hip circumference (cm) | −0.10 ± 0.17 | −0.10 ± 0.15 | 0.08 ± 0.16 | −0.05 ± 0.13 | 0.06 ± 0.15 | −0.10 ± 0.12 | −0.15 ± 0.08 | 0.15 ± 0.10 |
(−0.44, 0.25) | (−0.39, 0.21) | (−0.24, 0.39) | (−0.31, 0.21) | (−0.23, 0.36) | (−0.32, 0.14) | (−0.31, 0.02) | (−0.45, 0.33) | |
p-value | 0.582 | 0.533 | 0.619 | 0.696 | 0.670 | 0.411 | 0.084 | 0.132 |
Body mass index (BMI) | −0.42 ± 0.27 | 0.22 ± 0.23 | 0.13 ± 0.24 | 0.39 ± 0.20 | 0.28 ± 0.23 | 0.13 ± 0.18 | −0.08 ± 0.13 | −0.41 ± 0.15 |
(−0.95, 0.11) | (−0.25, 0.68) | (−0.36, 0.62) | (−0.01, 0.78) | (−0.18, 0.73) | (−0.22, 0.48) | (−0.33, 0.18) | (−0.70, −0.12) * | |
p-value | 0.116 | 0.355 | 0.587 | 0.056 | 0.230 | 0.473 | 0.554 | 0.006 * |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Thammachai, A.; Amput, P.; Wongphon, S. Factors Influencing Physical Performance and Quality of Life in Post-COVID-19 Patients. Diseases 2025, 13, 120. https://doi.org/10.3390/diseases13040120
Thammachai A, Amput P, Wongphon S. Factors Influencing Physical Performance and Quality of Life in Post-COVID-19 Patients. Diseases. 2025; 13(4):120. https://doi.org/10.3390/diseases13040120
Chicago/Turabian StyleThammachai, Ajchamon, Patchareeya Amput, and Sirima Wongphon. 2025. "Factors Influencing Physical Performance and Quality of Life in Post-COVID-19 Patients" Diseases 13, no. 4: 120. https://doi.org/10.3390/diseases13040120
APA StyleThammachai, A., Amput, P., & Wongphon, S. (2025). Factors Influencing Physical Performance and Quality of Life in Post-COVID-19 Patients. Diseases, 13(4), 120. https://doi.org/10.3390/diseases13040120